Combination therapy with serotonin reuptake inhibitors and interferon β-1a (Avonex) in the treatment of multiple sclerosis:: a pilot study

被引：0
|
作者：
Potter, DL
Hart, DE
机构：
来源：
ANNALS OF NEUROLOGY | 1999年 / 46卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：495 / 495
页数：1
相关论文
共 50 条
  • [31] Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study
    Kleinschnitz, Christoph
    Niemczyk, Gabriele
    Rehberg-Weber, Karin
    Wernsdoerfer, Colin
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (07): : 15271 - 15286
  • [32] A pilot study of the effect of weekly intramuscular 30 mcg interferon β-1a (Avonex™) on monthly gadolinium-enhanced brain MRI activity in patients with relapsing multiple sclerosis.
    Waubant, E
    Sloan, R
    Andersson, PB
    Goodkin, D
    [J]. REVUE NEUROLOGIQUE, 1999, 155 : S20 - S23
  • [33] Treatment of multiple sclerosis with a combination of interferon beta-1a (Avonex) and Mycophenolate mofetil (Cellcept): Results of a phase II clinical trial
    Vermersch, P
    Waucquier, N
    Bourteel, H
    Stojkovic, T
    Ferriby, D
    Michelin, E
    de Seze, J
    [J]. NEUROLOGY, 2004, 62 (07) : A259 - A259
  • [34] Acute demyelinating disease after interferon β-1a treatment for multiple sclerosis
    Von Raison, F
    Abboud, H
    Saint Val, C
    Brugières, P
    Césaro, P
    [J]. NEUROLOGY, 2000, 55 (09) : 1416 - 1417
  • [35] The multiple sclerosis PRISMS study:: Prevention of relapses and disability by interferon β-1a subcutaneously in multiple sclerosis
    Ebers, GC
    Oger, J
    Paty, D
    Li, D
    Freedman, M
    Hartung, HP
    Hommes, O
    McLeod, J
    Sandberg, M
    Wikström, J
    Carton, H
    Hughes, RAC
    Pancelius, M
    Medaer, R
    Blumhardt, L
    Barnes, D
    Bertelsmann, F
    Chofflon, M
    Kappos, L
    King, J
    Newsom-Davis, J
    Sindic, C
    Uitehaag, B
    Van Doom, P
    Bates, D
    Dupont, F
    Galazka, A
    Hyde, R
    Pernin, MO
    Abdul-Ahad, A
    [J]. ANNALS OF NEUROLOGY, 1997, 42 (06) : 986 - 986
  • [36] Interferon-β-1a (Avonex®) as treatment option for untreated MS patients (AXIOM)
    Kleinschnitz, C.
    Niemczyk, G.
    Rehberg-Weber, K.
    Wernsdoerfer, C.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 467 - 467
  • [37] A preliminary metabolomic study of patients with multiple sclerosis treated with interferon β 1a
    Cocco, E.
    Lorefice, L.
    Murgia, F.
    Barberini, L.
    Frau, J.
    Fenu, G.
    Coghe, G.
    Melis, M.
    Murru, M. R.
    Murru, R.
    Poddighe, S.
    Atzori, L.
    Marrosu, M. G.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 264 - 264
  • [38] Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis
    Minagar, Alireza
    Alexander, J. Steven
    Schwendimann, Robert N.
    Kelley, Roger E.
    Gonzalez-Toledo, Eduardo
    Jimenez, Joaquim J.
    Mauro, Lucia
    Jy, Wenche
    Smith, Stacy J.
    [J]. ARCHIVES OF NEUROLOGY, 2008, 65 (02) : 199 - 204
  • [39] A randomized, controlled trial of interferon-β-1a (Avonex®) in patients with rheumatoid arthritis: a pilot study [ISRCTN03626626]
    Mark C Genovese
    Eliza F Chakravarty
    Eswar Krishnan
    Larry W Moreland
    [J]. Arthritis Res Ther, 6
  • [40] Modulation of interleukin-16 by interferon β-1a treatment in patients with multiple sclerosis
    Nischwitz, S.
    Saemann, P. G.
    Knop, M.
    Mueller-Sarnowski, F.
    Faber, H.
    Yassouridis, A.
    Weber, F.
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S218 - S219
12345